Format

Send to

Choose Destination
Genome Med. 2017 May 30;9(1):43. doi: 10.1186/s13073-017-0433-1.

Genomic diagnosis for children with intellectual disability and/or developmental delay.

Author information

1
HudsonAlpha Institute for Biotechnology, 601 Genome Way, Huntsville, AL, 35806, USA.
2
University of Louisville, Louisville, KY, USA.
3
University of Alabama at Birmingham, Birmingham, AL, USA.
4
University of Alabama in Huntsville, Huntsville, AL, USA.
5
HudsonAlpha Institute for Biotechnology, 601 Genome Way, Huntsville, AL, 35806, USA. gcooper@hudsonalpha.org.

Abstract

BACKGROUND:

Developmental disabilities have diverse genetic causes that must be identified to facilitate precise diagnoses. We describe genomic data from 371 affected individuals, 309 of which were sequenced as proband-parent trios.

METHODS:

Whole-exome sequences (WES) were generated for 365 individuals (127 affected) and whole-genome sequences (WGS) were generated for 612 individuals (244 affected).

RESULTS:

Pathogenic or likely pathogenic variants were found in 100 individuals (27%), with variants of uncertain significance in an additional 42 (11.3%). We found that a family history of neurological disease, especially the presence of an affected first-degree relative, reduces the pathogenic/likely pathogenic variant identification rate, reflecting both the disease relevance and ease of interpretation of de novo variants. We also found that improvements to genetic knowledge facilitated interpretation changes in many cases. Through systematic reanalyses, we have thus far reclassified 15 variants, with 11.3% of families who initially were found to harbor a VUS and 4.7% of families with a negative result eventually found to harbor a pathogenic or likely pathogenic variant. To further such progress, the data described here are being shared through ClinVar, GeneMatcher, and dbGaP.

CONCLUSIONS:

Our data strongly support the value of large-scale sequencing, especially WGS within proband-parent trios, as both an effective first-choice diagnostic tool and means to advance clinical and research progress related to pediatric neurological disease.

KEYWORDS:

CSER; Clinical sequencing; De novo; Developmental delay; Intellectual disability

PMID:
28554332
PMCID:
PMC5448144
DOI:
10.1186/s13073-017-0433-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center